In a major milestone, Pakistan has successfully locally produced China’s single-dose CanSino COVID-19 vaccine in a bid to speed up its immunization drive, local media reported.
As per details, 124,000 doses of the vaccine have been prepared in the first phase with the help of Chinese experts. The raw material needed for the development of the vaccine was provided by the Chinese firm CanSino.
The vaccine will be made available by the next week after approval from the Drug Regulatory Authority of Pakistan (DRAP). The trial test of the vaccine is currently being held at the National Institute of Health’s (NIH) Quality Control Unit.
Earlier, the government decided that it will locally produce the CanSino COVID-19 vaccine with the help of China.
NIH Head Maj. Gen. Aamer Ikram told the parliament’s health committee that China’s single-dose CanSinoBio vaccine will be prepared locally.
He said Beijing agreed to transfer the technology for the vaccine to Islamabad while a Chinese team is overseeing the project at the NIH.